{"entity":{"id":"eu-pancare4aya","kind":"institution","name":"PanCare4AYA: late-effect follow-up for adolescent and young adult cancer survivors (EU Cancer Mission)","aka":["PanCare4AYA","AYA Cancer Survivor Screen"],"tldr":"A European Union project, coordinated by the Princess Máxima Center in Utrecht, that is writing a European guideline for checking young adult cancer survivors for late effects of treatment and testing it with 1,000 survivors in 11 countries.","summary":"PanCare4AYA (CORDIS project 101213107, topic HORIZON-MISS-2024-CANCER-01-05) runs from 1 April 2025 to 31 March 2030 with a total cost and EU contribution of about EUR 5.8 million, coordinated by the Princess Máxima Center for Paediatric Oncology in Utrecht. It will develop an international clinical guideline for late-effect screening and follow-up of survivors of adolescent and young adult (AYA) cancer and implement it through a person-centred programme, the AYA Cancer Survivor Screen, including peer support. An implementation study will involve 1,000 survivors in Croatia, the Czech Republic, France, Germany, Italy, Lithuania, the Netherlands, Norway, Sweden, Switzerland and the UK, measuring empowerment, mental health, psychosocial functioning and other quality-of-life outcomes, healthcare delivery, and feasibility, with digital tools in France, Italy, Lithuania and the Netherlands.","asOf":"2026-11-04","links":[{"label":"CORDIS: PanCare4AYA (101213107)","url":"https://cordis.europa.eu/project/id/101213107"}],"tags":["research-funding"],"related":["pancaresurfup"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["eu-mission-on-cancer","princess-maxima"],"pathways":[],"terms":["aya-oncology","late-effects"],"trials":[],"people":[],"bottlenecks":["b-survivorship"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Dates, costs and coordinator from the CORDIS project record (XML), read on 4 November 2026."],"city":"Utrecht","country":"NL","lat":52.085,"lng":5.171,"institutionType":"consortium","website":"https://cordis.europa.eu/project/id/101213107","programs":["International late-effect screening guideline for AYA survivors","AYA Cancer Survivor Screen implementation study (1,000 survivors, 11 countries)"]},"route":"/institutions/eu-pancare4aya/","neighbours":{"collection":[{"id":"pancaresurfup","kind":"collection","name":"PanCareSurFup and the European survivor cohorts","route":"/collections/pancaresurfup/"}],"institution":[{"id":"eu-mission-on-cancer","kind":"institution","name":"EU Mission on Cancer (Horizon Europe)","route":"/institutions/eu-mission-on-cancer/"},{"id":"princess-maxima","kind":"institution","name":"Princess Máxima Center for Pediatric Oncology","route":"/institutions/princess-maxima/"}],"term":[{"id":"aya-oncology","kind":"term","name":"Adolescent and young adult (AYA) oncology","route":"/terms/aya-oncology/"},{"id":"late-effects","kind":"term","name":"Late effects and survivorship toxicity","route":"/terms/late-effects/"}],"bottleneck":[{"id":"b-survivorship","kind":"bottleneck","name":"Survivorship and late effects are neglected","route":"/bottlenecks/b-survivorship/"}]}}